课题基金 / 基金详情

A pharmacological approach to reduce cognitive deficits in psychosis: Targeting of the dopamine D1 receptors.

A pharmacological approach to reduce cognitive deficits in psychosis: Targeting of the dopamine D1 receptors.
减少精神病认知缺陷的药理学方法：靶向多巴胺 D1 受体。
批准号：
292216
负责人：
Giros Bruno J
金额：
$49.49万
依托单位：
CIUSSS de l'Ouest-de-l'Ile-de-Montral-Douglas Hospital
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-09-01 至 2018-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=292216&lang=en
关键词：
Cognitive Deficits Pharmacology Pre-Clinical Models Schizophrenia

项目摘要

项目成果

Giros Bruno J的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Schizophrenia is a severe brain illness, which reaches more than 1% of the population, independently of the social and cultural background. Today, it is not possible to cure this disease, but only few of the symptoms could be alleviated, thanks to the use
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Noradrenergic control of vulnerability to chronic stress: novel mechanisms and targets
Understanding the complexity of dopamine transmission: Specific role of the neurons co-expressing D1 and D2 receptors.
CRC Tier 1
  • 批准号：
    314126
  • 项目类别：
  • 资助金额：
    $101.99万
  • 财政年份：
    2013
  • 负责人：
    Giros Bruno J
  • 依托单位：
    McGill University
Regulation of the Dopamine Transporter functional activity. Identification of new targets.
海外基金